Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal:: contribution and phylogenetic relatedness of serotype 14

被引:34
作者
Dias, R [1 ]
Caniça, M [1 ]
机构
[1] Natl Inst Hlth Dr Ricardo Jorge, Ctr Bacteriol, Antibiot Resistance Unit, P-1649016 Lisbon, Portugal
基金
美国国家卫生研究院; 英国惠康基金;
关键词
pneumococci; macrolide resistance; pulsed-field gel electrophoresis; multilocus sequence typing; international clones;
D O I
10.1093/jac/dkh469
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To study the phenotype and phylogenetic relatedness of invasive Streptococcus pneumoniae strains isolated in Portugal. Methods: A total of 614 invasive S. pneumoniae strains, isolated in Portugal from 1999 to the first 6 months of 2002, were characterized using serotyping and antimicrobial susceptibility testing. National outpatient sale data for macrolides were compared with erythromycin resistance. We investigated the main clonal lineages from erythromycin-resistant strains of serotype 14 by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Results: The emergence of erythromycin-resistant strains correlated well with the usage of azithromycin in Portugal during the period of the study (r=0.900, P=0.001). Serotype 14 made the largest contribution to this emergence. We found two clonal complexes (CC) among erythromycin-resistant strains: CC1 was formed by three sequence types (ST), ST156, ST143 and ST1042, and CC2 by ST15 and ST9. All STs described, except ST1042, are putative founders of clonal groups or subgroups from serotype 14 as defined in the pneumococcal MLST database. Conclusions: This study suggests that macrolides usage is an important factor enhancing the spread of invasive erythromycin-resistant S. pneumoniae clones in Portugal. The study also makes a contribution to the understanding of spread of erythromycin-resistant clones in an international context.
引用
收藏
页码:1035 / 1039
页数:5
相关论文
共 11 条
  • [1] [Anonymous], M100S10 NCCLS
  • [2] Emerging resistance to antimicrobial agents in gram-positive bacteria - Pneumococci
    Appelbaum, PC
    [J]. DRUGS, 1996, 51 : 1 - 5
  • [3] Two major Spanish clones of penicillin-resistant Streptococcus pneumoniae in Portuguese isolates of clinical origin
    Caniça, M
    Dias, R
    Vaz-Pato, MV
    Carvalho, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 409 - 414
  • [4] Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region
    Coffey, TJ
    Daniels, M
    Enright, MC
    Spratt, BG
    [J]. MICROBIOLOGY-SGM, 1999, 145 : 2023 - 2031
  • [5] Dot blot assay for the serotyping of pneumococci
    Fenoll, A
    Jado, I
    Vicioso, D
    Casal, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) : 764 - 766
  • [6] The Alexander Project 1998-2000:: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
    Jacobs, MR
    Felmingham, D
    Appelbaum, PC
    Grüneberg, RN
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) : 229 - 246
  • [7] Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network
    McGee, L
    McDougal, L
    Zhou, J
    Spratt, BG
    Tenover, FC
    George, R
    Hakenbeck, R
    Hryniewicz, W
    Lefévre, JC
    Tomasz, A
    Klugman, KP
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) : 2565 - 2571
  • [8] Pato MVV, 1995, MICROB DRUG RESIST, V1, P59
  • [9] Multilocus sequence typing of Streptococcus pneumoniae clones with unusual drug resistance patterns:: Genetic backgrounds and relatedness to other epidemic clones
    Sá-Leao, R
    Tomasz, A
    de Lencastre, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (09) : 1206 - 1210
  • [10] 3 DIFFERENT PHENOTYPES OF ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PYOGENES IN FINLAND
    SEPPALA, H
    NISSINEN, A
    YU, Q
    HUOVINEN, P
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (06) : 885 - 891